 Solid oral dosage forms of ifosfamide |
| OF PREFERRED EMBODIMENTS The invention is illustrated by the following examples: EXAMPLE 1 I... |
|
| [(benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted guanidines |
| We claim: 1. A compound of the formula: ##STR259## a pharmaceutically acceptable acid addition salt ... |
|
| Methods for treating dermatitis using descarboethoxyloratadine |
| OF THE INVENTION The present invention encompasses a method of treating allergic asthma in a human ... |
|
| Fat emulsions containing isocarbacyclin |
| What is claimed is: 1. A pharmaceutical prostaglandin emulsion comprising: a mixture of vegetable ... |
|
| Dermal pharmaceutical preparations |
| OF THE INVENTION The support which can be used in the present invention functions to retain a ... |
|
| Substituted iminodiacids, their preparation and pharmaceutical compositions containing them |
| We claim: 1. A compound selected from the group consisting of iminodiacid compounds having the ... |
|
| N-Acyl hexahydroindole-2-carboxylic acids and anti-hypertensive use thereof |
| We claim: 1. A compound of the formula I, ##STR24## in which n denotes 0 to 1, R denotes hydrogen, (... |
|
| Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as antihypertensive agents |
| OF THE INVENTION AND PREFERRED EMBODIMENTS In its broadest aspect, the present invention relates ... |
|
|
Oil composition
| Details |
Inventors: Koike, Shin; Hosoya, Naoki; Yasumasu, Takeshi;
Assignee: Kao Corporation (Tokyo, JP)
Primary Examiner: Weddington; Kevin E.
Assistant Examiner:
Attorney, Agent or Firm: Oblon, Spivak, McClelland, Maier & Neustadt, P.C.
The invention relates to oil composition comprising 0.1 to 59.8% by weight of a triglyceride, 40 to 99.7% by weight of a diglyceride, 0.1 to 10% by weight of a monoglyceride and at most 5% by weight of a free fatty acid, wherein contents of .omega.3 type unsaturated acyl groups having at least 20 carbon atoms and monoenoic acyl groups in acyl groups constituting the diglyceride are 15 to 89.5% by weight and 10 to 84.5% by weight, respectively; and oral medicinal compositions and foods comprising such an oil composition. The oil composition effectively develops physiological functions derived from .omega.3 type unsaturated fatty acids, such as inhibition of platelet aggregation, and is excellent in effect of facilitating combustion of body fat, oxidation stability, flavor and the like, and also excellent in flowability. |
|
DETAILED DESCRIPTION What is claimed is: 1.
An oil composition, comprising about 0.
1 to 59.
8% by weight of a triglyceride, about 40 to 99.
7% by weight of a diglyceride, about 0.
1 to 10% by weight of a monoglyceride, and at most about 5% by weight of a free fatty acid, wherein a content of .
omega.
3 unsaturated acyl groups having at least 20 carbon atoms and monoenoic acyl groups in acyl groups consisting the diglyceride are about 15 to 89.
5% by weight and about 10 to 84.
5% by weight, respectively.
2.
The oil composition of claim 1, which further comprises 0.
1 to 10% by weight of a glyceride polymer.
3.
The oil composition of claim 1, wherein a content of .
omega.
6 unsaturated acyl groups in acyl groups consisting the diglyceride is 0.
5 to 75% by weight.
4.
The oil composition of claim 1, wherein the triglyceride comprises 8 to 24 carbon atoms in acyl groups consisting the triglyceride.
5.
The oil composition of claim 4, wherein the triglyceride comprises 16 to 22 carbon atoms in acyl groups consisting the triglyceride.
6.
The oil composition of claim 1, wherein said triglyceride contains at least 55% of unsaturated acyl groups based upon all acyl groups present.
7.
The oil composition of claim 6, wherein said triglyceride contains at least 70% of unsaturated acyl groups based upon all acyl groups present.
8.
The oil composition of claim 7, wherein said triglyceride contains at least 90% of unsaturated acyl groups based upon all acyl groups present.
9.
The oil composition of claim 1, wherein said triglyceride is obtained from a vegetable oil, animal oil, fractionated oil or random transesterified oil thereof.
10.
The oil composition of claim 1, wherein said acyl groups comprising the diglyceride comprises said .
omega.
3 unsaturated acyl groups in an amount of 20 to 70% by weight, and said monoenoic acyl groups in an amount of 12 to 45%.
11.
The oil composition of claim 10, wherein said acyl groups comprising the diglyceride comprise said .
omega.
3 unsaturated acyl groups in an amount of 25 to 65% by weight, and said monoenoic acyl groups in an amount of 12 to 35%
|
|
Vasodialators 
